Johnson & Johnson to acquire Abiomed for $16.6B
Johnson & Johnson has made its move on M&A, announcing today that it will acquire Abiomed for approximately $16.6 billion.
Source: massdevice.com
ð° Michael Bodner News
Page 2 - Michael Bodner News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Bodner. Real-time updates on events, politics, business and more.
Johnson & Johnson to acquire Abiomed for $16.6B (updated)
Johnson & Johnson entered into a definitive agreement to acquire medical technology company Abiomed for approximately $16.6 billion.
Source: njbiz.com
Johnson & Johnson to Acquire Abiomed
Transaction to bring lifesaving innovations to more patients with unmet need
Source: dicardiology.com
Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations
Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR⢠Balloon Ablation Catheter.
Source: news-medical.net
Biosense Webster Launches HELIOSTAR in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations
The HELIOSTAR Balloon Ablation Catheter's unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solutionÂ
United States Bruxelles Capitale Johnson Medtech Gian Battista Chierchia Tillman Dahme Michael Bodner
Source: dicardiology.com
Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations
/PRNewswire/ -- Biosense Webster, Inc., part of Johnson & Johnson MedTechâ , today announced the European launch of the HELIOSTAR⢠Balloon Ablation Catheter â...
Source: prnewswire.com
Biosense Webster Launches the OCTARAY Mapping Catheter with TRUErefTechnology
The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias
Source: dicardiology.com
Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology
/PRNewswire/ -- Biosense Webster, Inc., part of Johnson & Johnson MedTechâ¡, today announced the release of the OCTARAY⢠Mapping Catheter with TRUErefâ¢...
Source: prnewswire.com
Biosense Webster, Inc.: Biosense Webster Launches the OCTARAY Mapping Catheter with TRUEref Technology
The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias1,2â IRVINE,
Source: finanznachrichten.de